IRD (STOCKS)
Opus Genetics, Inc. Common Stock
$5.520000
+0.160000 (+2.99%)
Prev close: $5.360000
Company Information
- Exchange
- XNAS
- Sector
- Health Technology
- Industry
- Pharmaceuticals: Major
- CEO
- George Magrath
- Asset Type
- stocks
- Website
- Visit
Fundamentals
- Market Cap
- $396.66M
- Employees
- 18
- P/E (TTM)
- -6.61
- P/B (TTM)
- 24.41
- Dividend Yield
- —
Technical Indicators
- SMA 10
- —
- SMA 20
- —
- SMA 50
- —
- EMA 9
- —
- EMA 21
- —
- RSI
- —
- MACD State
- —
Recent News
No recent news found for this ticker.
Financial Statements
| Revenues | $14.20M |
| Benefits Costs and Expenses | $63.79M |
| Costs And Expenses | $63.79M |
| Operating Expenses | $52.80M |
| Operating Income/Loss | -$38.60M |
| Income/Loss From Continuing Operations After Tax | -$49.59M |
| Income/Loss From Continuing Operations Before Tax | -$49.59M |
| Income Tax Expense/Benefit | $0.00 |
| Income Tax Expense/Benefit, Current | $0.00 |
| Net Income/Loss | -$49.59M |
| Net Income/Loss Attributable To Noncontrolling Interest | $0.00 |
| Net Income/Loss Attributable To Parent | -$49.59M |
| Net Income/Loss Available To Common Stockholders, Basic | -$49.59M |
| Participating Securities, Distributed And Undistributed Earnings/Loss, Basic | $0.00 |
| Preferred Stock Dividends And Other Adjustments | $0.00 |
| Basic Earnings Per Share | -$0.80 |
| Diluted Earnings Per Share | -$0.80 |
| Basic Average Shares | 62,221,901 |
| Diluted Average Shares | 62,221,901 |
| Assets | $50.24M |
| Current Assets | $50.04M |
| Noncurrent Assets | $199.00K |
| Fixed Assets | $199.00K |
| Liabilities | $34.90M |
| Current Liabilities | $7.78M |
| Accounts Payable | $3.29M |
| Wages | $1.99M |
| Other Current Liabilities | $2.50M |
| Noncurrent Liabilities | $27.11M |
| Equity | $15.35M |
| Equity Attributable To Noncontrolling Interest | $0.00 |
| Equity Attributable To Parent | $15.35M |
| Temporary Equity | $0.00 |
| Temporary Equity Attributable To Parent | $0.00 |
| Liabilities And Equity | $50.24M |
| Net Cash Flow From Operating Activities | -$35.25M |
| Net Cash Flow From Operating Activities, Continuing | -$35.25M |
| Net Cash Flow From Investing Activities | -$14.77M |
| Net Cash Flow From Investing Activities, Continuing | -$14.77M |
| Net Cash Flow From Financing Activities | $50.02M |
| Net Cash Flow From Financing Activities, Continuing | $50.02M |
| Net Cash Flow | $0.00 |
| Net Cash Flow, Continuing | $0.00 |
| Comprehensive Income/Loss | -$49.59M |
| Comprehensive Income/Loss Attributable To Noncontrolling Interest | $0.00 |
| Comprehensive Income/Loss Attributable To Parent | -$49.59M |
| Other Comprehensive Income/Loss | -$49.59M |